Evidence-Based Tobacco Cessation Strategies in Patients With Cancer
NCT ID: NCT02211196
Last Updated: 2018-07-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
377 participants
INTERVENTIONAL
2013-02-28
2014-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Enhanced Quitline Intervention in Smoking Cessation for Patients With Non-Metastatic Lung Cancer
NCT01457469
Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer
NCT00002520
Feasibility of Delivering a Quitline Based Smoking Cessation Intervention in Cancer Patients
NCT01434342
Smoking Cessation Intervention for Thoracic Patients
NCT00580398
Contingency Management to Promote Smoking Abstinence in Cancer Patients
NCT04605458
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
I. To assess oncology providers' self-reported need for training on evidence-based tobacco cessation strategies and assess their level of interest in future training on evidence-based tobacco cessation strategies.
II. To test the feasibility of the implementation of evidence-based tobacco cessation strategies in community oncology clinics.
III. To test the feasibility of surveying community oncology patients after a clinic visit to assess provider behavior regarding screening and brief intervention for tobacco use.
OUTLINE:
Patients complete a survey over approximately 10-15 minutes related to their provider's cessation advice and assistance with quitting.
After completion of study, patients are followed up at 1 month.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Health Services Research (smoking cessation intervention)
Participants complete a survey over approximately 10-15 minutes related to their provider's cessation advice and assistance with quitting.
smoking cessation intervention
Receive evidence-based tobacco cessation strategies
survey administration
Ancillary studies
questionnaire administration
Ancillary studies
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
smoking cessation intervention
Receive evidence-based tobacco cessation strategies
survey administration
Ancillary studies
questionnaire administration
Ancillary studies
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute (NCI)
NIH
Wake Forest University Health Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Erin Sutfin
Role: PRINCIPAL_INVESTIGATOR
Wake Forest University Health Sciences
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Comprehensive Cancer Center of Wake Forest University
Winston-Salem, North Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCI-2014-01572
Identifier Type: REGISTRY
Identifier Source: secondary_id
CCCWFU #99413
Identifier Type: OTHER
Identifier Source: secondary_id
IRB00021885
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.